Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity

Molecular Pharmacology

Volumn 74, Issue 6, 2008, Pages 1564-1575

  Hung, Shih Ya ^a   Liou, Houng Chi ^a   Kang, Kai Hsiang ^a   Wu, Ruey Meei ^b   Wen, Chun Chiang ^b   Fu, Wen Mei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ADENOVIRUS VECTOR; APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HEME OXYGENASE 1; INTERLEUKIN 1BETA; PROTOPORPHYRIN ZINC; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; GENE; GENE OVEREXPRESSION; HO 1 GENE; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYLPYRIDINIUM; ADENOVIRIDAE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; DOPAMINE; ENZYME INDUCTION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HEME OXYGENASE-1; HUMANS; INTERLEUKIN-1BETA; NEUROGLIA; NEURONS; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57349105151     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.048611     Document Type: Article

References (39)

1. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, and Kupiec-Weglinski JW (1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104:1631-1639.
2. Baranano DE, Rao M, Ferris CD, and Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 99:16093-16098.
3. Chen-Roetling J, Benvenisti-Zarom L, and Regan RF (2005) Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury. J Neurosci Res 82:802-810.
4. Chen K, Gunter K, and Maines MD (2000) Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75:304-313.
5. Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, et al. (2006) Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry 11:1116-1125.
6. Connor B and Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27:1-39.
7. Doré S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, and Snyder SH (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96:2445-2450.
8. Drummond GS and Kappas A (1981) Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A 78:6466-6470.
9. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, and Heywood P (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589-595.
10. Hornykiewicz O and Kish SJ (1987) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45:19-34.
11. Huang E, Ong WY, Go ML, and Garey LJ (2005) Heme oxygenase-1 activity after excitotoxic injury: immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase inhibition on neuronal survival after kainate treatment. J Neurosci Res 80:268-278.
12. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, and Chau LY (2001) Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104:1519-1525.
13. Kim HP, Wang X, Galbiati F, Ryter SW, and Choi AM (2004) Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 18:1080-1089.
14. + toxicity and oxidative stress in neonatal animals. Brain Res 713:178-185.
15. Lang AE and Lozano AM (1998a) Parkinson's disease. First of two parts. N Engl J Med 339:1044-1053.
16. Le WD, Xie WJ, and Appel SH (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res 56:652-658.
17. Lin LF, Doherty DH, Lile JD, Bektesh S, and Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
18. Lo Bianco C, Ridet JL, Schneider BL, Deglon N, and Aebischer P (2002) Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci U S A 99:10813-10818.
19. Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, and Gill SS (2005) Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med 11:703-704.
20. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, and Green CJ (2002) Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90:E17-E24.
21. Muñoz AM, Rey P, Parga J, Guerra MJ, and Labandeira-Garcia JL (2005) Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage. J Chem Neuroanat 29:113-126.
22. Olanow CW (1990) Oxidation reactions in Parkinson's disease. Neurology 40 (10 Suppl 3):32-37, discussion 37-39.
23. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, and Choi AM (1999) Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103:1047-1054.
24. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, et al. (2003) Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9:183-190.
25. Patel NK, Bunnage M, Plaha P, Svendsen CN, Heywood P, and Gill SS (2005) Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol 57:298-302.
26. Roberts PJ and Kapur H (1977) Neurochemical changes in rat striatum and substantia nigra following drug administration. Neurochem Res 2:485-494.
27. Ryter SW, Alam J, and Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583-650.
28. Schipper HM (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35:821-830.
29. Schipper HM (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 37:1995-2011.
30. Schipper HM, Cissé S, and Stopa EG (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37:758-768.
31. Schipper HM, Liberman A, and Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp Neurol 150:60-68.
32. + or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol Biochem Behav 84:321-329.
33. Smith A, Alam J, Escriba PV, and Morgan WT (1993) Regulation of heme oxygenase and metallothionein gene expression by the heme analogs, cobalt-, and tin-protoporphyrin. J Biol Chem 268:7365-7371.
34. Storch A, Ludolph AC, and Schwarz J (2004) Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm 111: 1267-1286.
35. Teng ZP, Chen J, Chau LY, Galunic N, and Regan RF (2004) Adenoviral transfer of the heme oxygenase-1 gene protects striatal astrocytes from heme-mediated oxidative injury. Neurobiol Dis 17:179-187.
36. Tenhunen R, Marver HS, and Schmid R (1969) Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244:6388-6394.
37. Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382:80-83.
38. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160.
39. Weisiger RA, Ostrow JD, Koehler RK, Webster CC, Mukerjee P, Pascolo L, and Tiribelli C (2001) Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem 276:29953-29960.